GlassScriptPhysician profile
Rajit Chakravarty
NPI 1396072187
$28,011.25
in general payments reported to CMS, 2019-2025
13 companies · $17K in 2025
The $17K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,119 · 2020: $523 · 2021: $237 · 2022: $806 · 2023: $2,782 · 2024: $4,127 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $6,068 · Food and Beverage: $4,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,966.94 |
| Travel and Lodging | $6,068.29 |
| Food and Beverage | $4,290.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $15,781.91 | 2025 | Velys |
| Zimmer Biomet Holdings, INC. | $5,578.89 | 2019-2024 | Rosa, Persona, Avenir |
| Stryker Corporation | $4,908.14 | 2019-2025 | Mako, Insignia |
| Depuy Synthes Sales INC. | $1,076.60 | 2023-2025 | Velys, Na, Attune |
| Medtronic USA, INC. | $400.37 | 2019-2020 | |
| Smith+Nephew, INC. | $87.36 | 2025 | Real Intelligence |
| Pacira Pharmaceuticals Incorporated | $42.80 | 2023-2024 | Zilretta, Iovera, Exparel |
| Bioventus LLC | $39.38 | 2025 | Xcell |
| Paragon 28, INC. | $26.51 | 2025 | |
| Ethicon US, LLC | $19.56 | 2025 | Ethicon, Vistaseal |
| Enduromed, LLC | $18.24 | 2025 | |
| Orthofix Medical, INC. | $16.26 | 2022 | |
| Heraeus Medical, LLC. | $15.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajit Chakravarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.